The US FDA has approved SYNRIBO from Israel’s Teva for the treatment of patients with Chronic Myeloid Leukemia who failed therapy using tyrosine kinase inhibitors.
http://www.tevapharm.com/Media/News/Pages/2014/1899845.aspx?year=2014
US approval for Leukemia treatment
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.